MannKind Corp (MNKD)
7.02
+0.06
(+0.86%)
USD |
NASDAQ |
Nov 14, 16:00
7.26
+0.24
(+3.42%)
Pre-Market: 08:36
MannKind Cash from Financing (Quarterly): -2.342M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.342M |
| June 30, 2024 | -44.55M |
| March 31, 2024 | -3.474M |
| December 31, 2023 | 141.68M |
| September 30, 2023 | -0.283M |
| June 30, 2023 | -5.945M |
| March 31, 2023 | 1.154M |
| December 31, 2022 | 2.825M |
| September 30, 2022 | 19.53M |
| June 30, 2022 | -1.776M |
| March 31, 2022 | 0.813M |
| December 31, 2021 | 97.37M |
| September 30, 2021 | -0.59M |
| June 30, 2021 | -51.49M |
| March 31, 2021 | 224.98M |
| December 31, 2020 | 18.69M |
| September 30, 2020 | 2.64M |
| June 30, 2020 | 28.19M |
| March 31, 2020 | 0.331M |
| December 31, 2019 | 5.042M |
| September 30, 2019 | 65.50M |
| June 30, 2019 | -0.676M |
| March 31, 2019 | 0.003M |
| December 31, 2018 | 35.97M |
| September 30, 2018 | -1.823M |
| Date | Value |
|---|---|
| June 30, 2018 | 26.62M |
| March 31, 2018 | 0.528M |
| December 31, 2017 | 58.24M |
| September 30, 2017 | -0.022M |
| June 30, 2017 | 15.42M |
| March 31, 2017 | -0.075M |
| December 31, 2016 | 0.117M |
| September 30, 2016 | -5.132M |
| June 30, 2016 | 47.59M |
| March 31, 2016 | 0.464M |
| December 31, 2015 | 49.01M |
| September 30, 2015 | -53.21M |
| June 30, 2015 | 8.686M |
| March 31, 2015 | 1.186M |
| December 31, 2014 | -1.667M |
| September 30, 2014 | 31.23M |
| June 30, 2014 | 37.13M |
| March 31, 2014 | 3.368M |
| December 31, 2013 | 17.20M |
| September 30, 2013 | 98.41M |
| June 30, 2013 | 30.40M |
| March 31, 2013 | -0.349M |
| December 31, 2012 | 88.23M |
| September 30, 2012 | 4.508M |
| June 30, 2012 | 0.386M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-51.49M
Minimum
Jun 2021
224.98M
Maximum
Mar 2021
21.64M
Average
0.9835M
Median
Cash from Financing (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 7.291M |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | 5.991M |
| iBio Inc | 12.99M |
| Theriva Biologics Inc | 1.773M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.331M |
| Cash from Investing (Quarterly) | -41.26M |
| Free Cash Flow | 28.87M |
| Free Cash Flow Per Share (Quarterly) | 0.0278 |
| Free Cash Flow to Equity (Quarterly) | 7.55M |
| Free Cash Flow to Firm (Quarterly) | 12.56M |
| Free Cash Flow Yield | 1.43% |